We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$41.1B
AUM Growth
+$5.37B
Cap. Flow
+$2.44B
Cap. Flow %
5.94%
Top 10 Hldgs %
24.49%
Holding
1,526
New
158
Increased
755
Reduced
338
Closed
110

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$170M
2
TSLA icon
Tesla
TSLA
+$155M
3
NVDA icon
NVIDIA
NVDA
+$116M
4
TSM icon
TSMC
TSM
+$87.6M
5
NTR icon
Nutrien
NTR
+$86.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$150M
2
NOC icon
Northrop Grumman
NOC
+$112M
3
HON icon
Honeywell
HON
+$98.1M
4
LIN icon
Linde
LIN
+$87M
5
UBER icon
Uber
UBER
+$72.9M

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Healthcare 16.16%
3 Financials 10.71%
4 Consumer Discretionary 9.79%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMTI
1501
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
– –
-11,000
Closed -$290K
ICPT
1502
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-11,090
Closed -$167K
NATI
1503
DELISTED
National Instruments Corp
NATI
– –
-57,200
Closed -$2.24M
PTRA
1504
DELISTED
Proterra Inc. Common Stock
PTRA
– –
-480,000
Closed -$4.84M
SPPI
1505
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-42,800
Closed -$95K
DSEY
1506
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
– –
-50,000
Closed -$832K
TCRR
1507
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-13,000
Closed -$108K
PRVB
1508
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-20,000
Closed -$126K
ATNX
1509
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-1,595
Closed -$93K
TCDA
1510
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-16,500
Closed -$76K
CLVS
1511
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-28,000
Closed -$124K
AKUS
1512
DELISTED
Akouos Inc
AKUS
– –
-11,000
Closed -$126K
AERI
1513
DELISTED
Aerie Pharmaceuticals
AERI
– –
-12,100
Closed -$136K
FMTX
1514
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-5,000
Closed -$111K
RDUS
1515
DELISTED
Radius Health, Inc.
RDUS
– –
-15,200
Closed -$197K
EPZM
1516
DELISTED
Epizyme, Inc
EPZM
– –
-32,300
Closed -$165K
ARNA
1517
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-26,950
Closed -$1.59M
ODT
1518
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
– –
-14,000
Closed -$42K
KSU
1519
DELISTED
Kansas City Southern
KSU
– –
-73,987
Closed -$20.2M
HRC
1520
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-19,400
Closed -$2.92M
PPD
1521
DELISTED
PPD, Inc. Common Stock
PPD
– –
-9,333
Closed -$454K
XLRN
1522
DELISTED
Acceleron Pharma
XLRN
– –
-26,750
Closed -$4.74M
KDMN
1523
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-55,000
Closed -$473K
RPAI
1524
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
– –
-136,634
Closed -$1.77M
XEC
1525
DELISTED
CIMAREX ENERGY CO
XEC
– –
-3,350
Closed -$299K
58 59 60
61
62

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q4 2021 Portfolio in Review

As of Q4 2021, DekaBank Deutsche Girozentrale held 1,526 positions worth $41.1B, up 15% from $35.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

DekaBank Deutsche Girozentrale deployed $2.44B of net new capital in Q4 2021, opening 158 new positions and adding to 755 existing holdings. Its largest new stake was Regal Rexnord: 103,299 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $150M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2021 buy was Regal Rexnord: 103,299 shares worth $17.6M.
  • DekaBank Deutsche Girozentrale added most to Mastercard in Q4 2021, an estimated $170M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2021 reduction was Visa, cutting an estimated $150M.
  • DekaBank Deutsche Girozentrale fully exited Kansas City Southern in Q4 2021, selling an estimated $20.2M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $41.1B portfolio in Q4 2021.
  • DekaBank Deutsche Girozentrale opened 158 new positions and closed 110 in Q4 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 15% quarter-over-quarter to $41.1B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.